NARAYANA HRUDAYALAYA
|
NARAYANA HRUDAYALAYA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 29.68 | 16.74 | -0.70 | 5.82 | 2.90 |
| CEPS(Rs) | 39.96 | 25.72 | 8.62 | 15.08 | 9.74 |
| DPS(Rs) | 2.50 | 1.00 | - | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 104.26 | 72.69 | 54.64 | 55.42 | 52.78 |
| Tax Rate(%) | 19.29 | 20.40 | 84.85 | 25.65 | 35.64 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 21.67 | 17.92 | 7.32 | 13.65 | 10.31 |
| EBIT Margin(%) | 18.47 | 13.67 | 1.28 | 8.27 | 6.17 |
| Pre Tax Margin(%) | 16.61 | 11.61 | -1.91 | 5.27 | 3.35 |
| PAT Margin (%) | 13.41 | 9.24 | -0.29 | 3.92 | 2.15 |
| Cash Profit Margin (%) | 18.05 | 14.20 | 6.82 | 9.86 | 6.95 |
| Performance Ratios | |||||
| ROA(%) | 16.64 | 11.59 | -0.26 | 4.44 | 2.39 |
| ROE(%) | 33.55 | 26.30 | -0.66 | 11.08 | 5.87 |
| ROCE(%) | 33.92 | 26.83 | 1.84 | 13.80 | 9.46 |
| Asset Turnover(x) | 1.24 | 1.25 | 0.91 | 1.13 | 1.11 |
| Sales/Fixed Asset(x) | 1.33 | 1.21 | 0.87 | 1.15 | 1.17 |
| Working Capital/Sales(x) | 14.75 | 28.75 | -67.78 | -201.77 | 168.05 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.75 | 0.83 | 1.15 | 0.87 | 0.85 |
| Receivable days | 35.02 | 35.27 | 38.21 | 30.85 | 34.79 |
| Inventory Days | 5.28 | 5.29 | 7.64 | 8.37 | 10.64 |
| Payable days | 193.96 | 172.49 | 207.83 | 170.21 | 169.49 |
| Valuation Parameters | |||||
| PER(x) | 26.08 | 44.59 | - | 42.53 | 73.83 |
| PCE(x) | 19.37 | 29.03 | 47.13 | 16.40 | 21.95 |
| Price/Book(x) | 7.42 | 10.27 | 7.43 | 4.46 | 4.05 |
| Yield(%) | 0.32 | 0.13 | - | 0.40 | 0.47 |
| EV/Net Sales(x) | 3.58 | 4.22 | 3.40 | 1.81 | 1.78 |
| EV/Core EBITDA(x) | 15.49 | 22.40 | 40.55 | 12.43 | 16.19 |
| EV/EBIT(x) | 19.39 | 30.90 | 265.26 | 21.89 | 28.78 |
| EV/CE(x) | 3.90 | 4.99 | 3.17 | 1.96 | 1.93 |
| M Cap / Sales | 3.50 | 4.12 | 3.21 | 1.62 | 1.53 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 22.25 | 43.29 | -17.42 | 9.33 | 25.43 |
| Core EBITDA Growth(%) | 49.87 | 222.13 | -52.41 | 45.03 | 31.35 |
| EBIT Growth(%) | 65.19 | 1,427.48 | -87.19 | 46.48 | 26.48 |
| PAT Growth(%) | 77.30 | 4,687.90 | -106.09 | 98.80 | 9.95 |
| EPS Growth(%) | 77.30 | 2,491.91 | -112.03 | 100.98 | 15.23 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.36 | 0.37 | 0.55 | 0.63 | 0.75 |
| Current Ratio(x) | 1.31 | 1.16 | 0.95 | 0.97 | 1.03 |
| Quick Ratio(x) | 1.24 | 1.09 | 0.88 | 0.87 | 0.87 |
| Interest Cover(x) | 9.94 | 6.65 | 0.40 | 2.76 | 2.18 |
| Total Debt/Mcap(x) | 0.05 | 0.04 | 0.07 | 0.14 | 0.19 |
Compare Financial Ratios of peers of NARAYANA HRUDAYALAYA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NARAYANA HRUDAYALAYA | ₹25,349.7 Cr | 2% | -9.6% | 59.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹87,250.7 Cr | 3.4% | -6.6% | 49% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹75,430.1 Cr | 5.7% | -8.7% | 59.1% | Stock Analytics | |
| GLOBAL HEALTH | ₹36,829.8 Cr | 6.7% | -13.1% | 164.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹32,904.9 Cr | 2.6% | -6.4% | 59.4% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹26,077.1 Cr | 1.9% | -6.1% | 86.2% | Stock Analytics | |
NARAYANA HRUDAYALAYA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NARAYANA HRUDAYALAYA | 2% |
-9.6% |
59.5% |
| SENSEX | -2.9% |
-0.4% |
20% |
You may also like the below Video Courses
